C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
United Kingdom
Recent Filings
- SCHEDULE 13G/A19.2 KBCentessa Pharmaceuticals plcAug 4, 11:41 AM ET·0001193125-26-332020
- 8-K212.3 KBCentessa Pharmaceuticals plcJun 24, 8:56 AM ET·0001193125-26-280337
- 8-K220.9 KBCentessa Pharmaceuticals plcJun 12, 4:15 PM ET·0001193125-26-269474
- 8-K201.5 KBCentessa Pharmaceuticals plcMay 22, 4:15 PM ET·0001193125-26-236933
- 10-Q12.3 MBCentessa Pharmaceuticals plcMay 5, 4:04 PM ET·0001847903-26-000049
- 10-K20.5 MBCentessa Pharmaceuticals plcMar 31, 4:31 PM ET·0001847903-26-000025
- 8-K1.3 MBCentessa Pharmaceuticals plcMar 31, 4:21 PM ET·0001193125-26-134656
- 8-K189.2 KBCentessa Pharmaceuticals plcFeb 13, 4:16 PM ET·0001193125-26-051424
- 8-K/A361.8 KBCentessa Pharmaceuticals plcJan 6, 6:23 PM ET·0001193125-26-004896
- 8-K217.6 KBCentessa Pharmaceuticals plcDec 11, 7:51 AM ET·0001193125-25-315074
Insiders
10- Accardi Mario AlbertoDirector, Chief Executive Officer
- Anderson Karen M.Chief People Officer
- Bush Tia LChief Technology & Quality Ofc
- Califf RobertDirector
- CHAO DAVID MChief Administrative Officer
- Crowley John JChief Financial Officer
- Deferiere RaphaelChief Accounting Officer
- De Rubertis FrancescoDirector
- GAP (Bermuda) L.P.Director, 10% Owner
- General Atlantic Cooperatief U.A.Director, 10% Owner
Tickers
No tickers on record
Addresses
business
3RD FLOOR 1 ASHLEY ROAD
ALTRINCHAM, CHESHIRE, X0, WA14 2DT
mailing
3RD FLOOR 1 ASHLEY ROAD
ALTRINCHAM, CHESHIRE, X0, WA14 2DT
Former Names
- Centessa Pharmaceuticals Ltd2021-05-24